Arjen J. Witkamp

Personalized response-directed surgery and adjuvant therapy after neoadjuvant ipilimumab and nivolumab in high-risk stage III melanoma: the PRADO trial

Irene L. M. Reijers, Alexander M. Menzies, Alexander C. J. van Akkooi et al. · Nature Medicine · 2022 · 322 citations · Full text

Surgical Oncology, Oncology, Prado Trial +10

Adjuvant hyperthermic intraperitoneal chemotherapy in patients with locally advanced colon cancer (COLOPEC): a multicentre, open-label, randomised trial

Charlotte E.L. Klaver, D D Wisselink, Cornelis J.A. Punt et al. · ˜The œLancet. Gastroenterology & hepatology · 2019 · 312 citations · Full text

Health Sciences, Gastrointestinal Oncology, Medicine +8

Tumor-Specific Uptake of Fluorescent Bevacizumab–IRDye800CW Microdosing in Patients with Primary Breast Cancer: A Phase I Feasibility Study

Laetitia E. Lamberts, Maximillian Koch, Johannes S. de Jong et al. · Clinical Cancer Research · 2016 · 267 citations · Full text

Long-Term Survival of Peritoneal Carcinomatosis of Colorectal Origin

Victor J. Verwaal, Serge van Ruth, Arjen J. Witkamp et al. · Annals of Surgical Oncology · 2004 · 265 citations

Surgical Oncology, Colorectal Surgery, Medicine +7

Extensive cytoreductive surgery followed by intra-operative hyperthermic intraperitoneal chemotherapy with mitomycin-C in patients with peritoneal carcinomatosis of colorectal origin

Arjen J. Witkamp, Eelco de Bree, M. Kaag et al. · European Journal of Cancer · 2001 · 201 citations

Colorectal Origin, Surgical Oncology, Gastrointestinal Oncology +10